Skip to content

Early Treatments for Preventing Occlusal Caries Lesions

Clinical Effectiveness of Early Treatments for Preventing Occlusal Caries Lesions in Erupting Permanent Molars

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05969756
Enrollment
132
Registered
2023-08-01
Start date
2023-07-31
Completion date
2024-10-15
Last updated
2026-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caries,Dental, Caries; Initial, Occlusal Caries

Keywords

early caries lesions, sealants, erupting molars

Brief summary

Sealants effectively arrest non-cavitated caries lesions on the fully erupted occlusal surface of permanent teeth. However, the clinical effectiveness of sealants is uncertain in preventing occlusal caries lesions in partially erupted permanent molars. This study aims to evaluate the progression of caries, the degree of retention, survival rate, and quality of the remnant after applying conventional total-etch resinous sealant and self-etch sealant in erupting molars.

Interventions

DRUGFluoride varnish

Thirty-eight permanent molars will receive 5% sodium fluoride varnish application every three months

DRUGConventional etch and rinse sealant

Thirty-eight permanent molars will receive conventional etch and rinse sealant

DRUGSelf-etch sealant

Thirty-eight permanent molars will receive self-etch sealant

Sponsors

Hue University of Medicine and Pharmacy
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

Blinding of examiners is impossible to be done during intervention and follow up due to different natures of the materials. However, participants and outcome assessors could be blinded (double blinding).

Intervention model description

This is a 3 arm clinical trial. All selected permanent molars will be randomly equally allocated into three groups according to material used.

Eligibility

Sex/Gender
ALL
Age
5 Years to 14 Years
Healthy volunteers
Yes

Inclusion criteria

For children: 1. Children presenting with good general health and cooperative behavior. 2. Children having early caries lesions in a permanent molar (first or second). 3. Parents signed informed consent. For permanent molars: 1. Early caries lesions on the occlusal surface corresponding to International Caries Detection and Assessment System (ICDAS) scores 1 and 2. \[Ismail AI, Sohn W, Tellez M, Amaya A, Sen A, Hasson H, Pitts NB. The International Caries Detection and Assessment System (ICDAS): an integrated system for measuring dental caries. Community Dent Oral Epidemiol. 2007 Jun;35(3):170-8\]. 2. Erupting molars: eruption stages 2 (fully erupted occlusal surface with less than half of the crown exposed) and 3 (fully erupted occlusal surface with more than half of the crown exposed). \[Carvalho JC, Ekstrand KR, Thylstrup A. Dental plaque and caries on occlusal surfaces of first permanent molars in relation to stage of eruption. J Dent Res. 1989 May;68(5):773-9\].

Exclusion criteria

For children: 1. Any allergy reported by the parents. 2. Children unable to return for recall visits. For permanent molars: 1. Teeth with occlusal surfaces completely covered by the gingival tissue. 2. Teeth with hypoplastic defects, restorations, or sealants.

Design outcomes

Primary

MeasureTime frameDescription
Development of new caries lesion3 monthsICDAS was considered "0'' for fully sealed teeth. A score of ICDAS≥1 was considered as new caries lesion

Secondary

MeasureTime frameDescription
Sealants retention3 monthsSealant retention was assessed as follows: total retention of sealant on the occlusal surface or the partial or complete absence of the sealant on the occlusal surface.
Quality of sealants3 monthsQuality of the remnant United States Public Health Service criteria (USPHS): anatomical shape, marginal adaptation, surface texture, and marginal discoloration.

Countries

Vietnam

Contacts

PRINCIPAL_INVESTIGATORVan Nhat Thang Le, DDS, PhD

Hue University of Medicine and Pharmacy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 15, 2026